MH
Monica Hemal Kanuga
About Monica Hemal Kanuga
Data last updated:
Monica Hemal Kanuga is a Director at Corona Remedies Limited (since 2024). The companies operate in Pharma, Machinery and Equipment and Chemicals and Materials. Corona Remedies Limited reported revenue of ₹1,202 Cr (FY 2025). Earlier, Monica Hemal Kanuga was a Director at Shilp Gravures Limited (2014–2025) and Director at Resinova Chemie Limited (2016–2020).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Corona Remedies Limited L24231GJ2004PLC044656 | Director | 24 Oct 2024 | 2004 | ₹1,202 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Shilp Gravures Limited L27100GJ1993PLC020552 | Director | 26 Jul 2014 | 1993 | ₹94.69 Cr (FY 2025) | Active |
 Resinova Chemie Limited U24295GJ2009PLC058120 | Director | 11 Feb 2016 | 2009 | ₹482 Cr (FY 2021) | Amalgamated |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Monica Hemal Kanuga
| Name | DIN | Company | Designation |
|---|---|---|---|
| Ameetkumar Hiranyakumar Desai | 00007116 | Corona Remedies Limited | Director |
| Ankur Kirtikumar Mehta | 00385547 | Corona Remedies Limited | Managing Director |
| Bhaskar Vemban Iyer | 00480341 | Corona Remedies Limited | Director |
| Bhavin Nareshbhai Bhagat | Corona Remedies Limited | Cfo | |
| Chetna Prabhatkumar Dharajiya | Corona Remedies Limited | Company Secretary | |
| Kirtikumar Laxmidas Mehta | 00385658 | Corona Remedies Limited | Director |
| Niravkumar Kirtikumar Mehta | Corona Remedies Limited | Ceo | |
| Niravkumar Kirtikumar Mehta | 01644041 | Corona Remedies Limited | Managing Director |
| Shirish Gundopant Belapure | 02219458 | Corona Remedies Limited | Director |
| Viral Sitwala | 02907957 | Corona Remedies Limited | Whole-Time Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Monica Hemal Kanuga
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Monica Hemal Kanuga
Monica Hemal Kanuga currently holds 1 directorship: Corona Remedies Limited (Director, since 24 Oct 2024, revenue ₹1,202 Cr (FY 2025)).
Monica Hemal Kanuga was first appointed on 26 Jul 2014 as Director at Shilp Gravures Limited. The most recent appointment on record is 24 Oct 2024 at Corona Remedies Limited.
Monica Hemal Kanuga held 2 earlier board appointments: Shilp Gravures Limited (Director, 26 Jul 2014 to 07 Aug 2025); Resinova Chemie Limited (Director, 11 Feb 2016 to 25 Aug 2020).
The current boards of Monica Hemal Kanuga's companies include Ameetkumar Hiranyakumar Desai (Corona Remedies Limited), Ankur Kirtikumar Mehta (Corona Remedies Limited), Bhaskar Vemban Iyer (Corona Remedies Limited), Bhavin Nareshbhai Bhagat (Corona Remedies Limited), Chetna Prabhatkumar Dharajiya (Corona Remedies Limited), Kirtikumar Laxmidas Mehta (Corona Remedies Limited), among others.